The National Institute for Health and Care Research (NIHR) is the UK’s largest single funder of health and social care research. For a research administrator or investigator working in or with a UK institution, “NIHR funding” covers a specific family of programmes distinct from both UK Research and Innovation (UKRI) and NHS clinical service funding — understanding where NIHR sits in that landscape, and how its major programme families work, is the first step to finding the right opportunity.
What NIHR is and what it funds
NIHR is an executive non-departmental public body of the UK’s Department of Health and Social Care (DHSC), established in 2006 to fund, enable, and coordinate applied health and social care research. Its remit is primarily research relevant to England’s NHS and social care system: developing new treatments and diagnostics, evaluating existing interventions and services, and supporting the workforce and infrastructure that delivers that research. NIHR works in partnership with the NHS, universities, local government, other research funders, and patients and the public rather than funding research in isolation.
NIHR does not fund itself — it is DHSC’s delivery arm for applied health research funding, distinct from a self-standing research council in the way MRC or ESRC are constituent councils of UKRI.
NIHR vs. UKRI: how the two relate
NIHR and UKRI are separate funders with overlapping but distinct remits, and researchers new to the UK system often conflate them. UKRI is the umbrella body for the UK’s seven discipline-based research councils (including the Medical Research Council, MRC) plus Research England and Innovate UK, covering the full span of academic disciplines from arts and humanities through engineering and biomedicine. NIHR, by contrast, is DHSC’s applied-research funder, focused specifically on health and social care research with direct relevance to patients, the NHS, and care services — more translational and service-facing than MRC’s typically more discovery-oriented biomedical science remit.
The two bodies collaborate rather than compete: NIHR and MRC jointly fund cross-cutting programmes such as the Efficacy and Mechanism Evaluation (EME) programme and the Methodology Research programme, reflecting the genuine overlap between applied clinical evaluation and underpinning biomedical/methodological science. A researcher assembling a UK grants strategy typically needs to know both systems, since a single research group’s portfolio might span an MRC discovery grant, an NIHR applied trial, and a UKRI doctoral training studentship at the same time.
NIHR’s relationship to the NHS
NIHR is often described as the research arm of the NHS, though the relationship is one of partnership rather than direct ownership. NIHR funding delivers research that is conducted largely within and alongside NHS organisations — NHS trusts host trials, NHS clinicians act as investigators, and NIHR’s research-delivery infrastructure (the NIHR Clinical Research Network) supports NHS sites in recruiting patients and running studies. NIHR funding is separate from routine NHS clinical service budgets: it is research funding awarded competitively against specific programmes, not part of an NHS trust’s core commissioning allocation, though the research it funds is designed to feed directly back into NHS and social care practice.
Major NIHR funding programme families
NIHR organises its funding into several distinct programme families rather than a single generic grant. The exact list of open calls changes continuously, so treat the categories below as the map, not a substitute for checking current opportunities directly — but the family names are stable and worth knowing before searching:
- Research for Patient Benefit (RfPB) — funds developmental and evaluative research aimed at improving patient and service-user outcomes in the NHS and social care in England, administered regionally and particularly aimed at early-career researchers and health and care professionals rather than established academic PIs only.
- Health Technology Assessment (HTA) Programme — commissions research that produces evidence on the clinical and cost-effectiveness of health technologies and interventions, structured around researcher-led primary research and evidence-synthesis strands, as well as commissioned calls responding to specific evidence gaps (including a rolling arrangement with NICE). HTA applications typically proceed through a staged process (an initial outline application followed by a detailed full application for shortlisted proposals).
- Research Professorships — NIHR’s flagship senior career award: five-year funding for a small number of outstanding academics (up to five per annual round) to support translation of research into patient and public benefit, awarded through annual nomination-based competitions.
- Research career funding programmes (the NIHR Academy) — a structured ladder of career-stage fellowships and training awards spanning pre-doctoral through advanced/senior fellowship level, intended to build individual researchers’ careers rather than fund a single project. Current award names and eligibility criteria change periodically, so check NIHR’s career-development pages directly rather than relying on a fixed list.
- Infrastructure funding — longer-term institutional awards such as Biomedical Research Centres (BRCs), Applied Research Collaborations (ARCs), and Patient Safety Research Collaborations, which fund the research environment and delivery capacity at a partnership of NHS and university sites rather than a single study.
How researchers find and apply for current NIHR opportunities
NIHR publishes and searches all open calls through its central funding-opportunities listing on nihr.ac.uk, which can be filtered by programme, research stage, and closing date — there is no separate portal per programme family. Because calls open and close on a rolling basis throughout the year, the practical starting point for any NIHR application is checking that listing directly rather than assuming a programme’s timeline from a prior round.
Application mechanics vary by programme: some (like RfPB and HTA researcher-led calls) run as competitive calls open to any eligible applicant with a specific research question; others (like commissioned HTA calls or Research Professorships) are targeted at a defined evidence gap or a nominated individual. Multi-stage assessment is common for larger awards — an outline or Stage 1 application assessed for fit and feasibility, followed by an invited full application for shortlisted proposals — so research administrators should build realistic lead time into an institutional pipeline rather than treating NIHR calls as single-stage submissions.
Frequently asked questions
Is NIHR the same as UKRI?
No. NIHR is DHSC’s applied health and social care research funder; UKRI is the umbrella body for the UK’s seven discipline research councils (including MRC), Research England, and Innovate UK, spanning all academic disciplines. They are separate organisations that collaborate on specific cross-cutting programmes rather than one being part of the other.
Who funds NIHR itself?
NIHR is funded by the Department of Health and Social Care as an executive non-departmental public body, rather than raising its own independent endowment or being a constituent part of UKRI.
What is the NIHR Academy?
The NIHR Academy is the umbrella term for NIHR’s structured programme of career-development and training awards, spanning career stages from pre-doctoral training through advanced and senior fellowship levels, alongside the flagship Research Professorships scheme.
Is NIHR funding only available to NHS-employed researchers?
No. NIHR funds researchers based in universities, NHS organisations, and other eligible health and social care providers; many programmes, including RfPB, explicitly target early-career researchers and health and care professionals as well as established academic investigators. Specific eligibility criteria vary by programme and should be checked against the individual call.
How does NIHR funding differ from routine NHS research support?
NIHR funding is competitively awarded research funding for specific programmes and studies, separate from an NHS trust’s core clinical service budget. NIHR’s delivery infrastructure, including the Clinical Research Network, supports NHS sites in running NIHR-funded (and other) studies, but that support function is distinct from the grant funding itself.
Related CASRAI resources
For the broader UK funding landscape this guide sits alongside, see the UKRI R4RI mandate and the NIH biosketch vs UKRI R4RI comparison for how UK narrative-CV requirements differ from the US NIH biosketch. On patient involvement, which NIHR requires across most of its research programmes, see Patient and Public Involvement (PPI). For the clinical-trial infrastructure NIHR funding often supports directly, see Clinical Trials Unit (CTU) and Clinical Trial Registration and Reporting Compliance. NIHR is also the sole funder of PROSPERO, the international register of systematic reviews. For the equivalent US federal funding-agency orientation, see NIH Grants: An Overview.
